search for

About Borui

All categories
  • 2001year

    Borui Pharmaceutical was established
  • 2006year

    Developed Entecavir synthetic process with independent property rights
  • 2010year

    Established a wholly-owned subsidiary, Xintai Pharmaceutical
  • 2012year

    Founder Dr. Yuan Jiandong selected into the "Thousand Talents Program"
  • 2013year

    Xintai Pharmaceutical, a wholly-owned subsidiary, was completed and put into operation, and Borui became a pharmaceutical group of the entire industry chain;
    Passed cGMP certification of FDA for the first time
  • 2015year

    Completed the shareholding system transformation and renamed Borui Biomedical (Suzhou) Co., Ltd .;
    Xintai Pharmaceutical and Borui Taixing both passed the new domestic GMP certification
  • 2016year

    Passed the cGMP inspection of EU EMDA for the first time;
    Passed FDA cGMP certification again
  • 2017year

    "Zero defect" passed the US FDA inspection;
    Caspofungin injection is marketed in Europe;
    Passed KFDA official certification for the first time;
    Passed Japan PMDA official certification for the first time
  • 2019year

    Science and technology board listed
    First US ANDA approved

Back to top ▲

Borui Medicine


Building C25-28, 218 Xinghu Road, Suzhou Industrial Park, Jiangsu Province, China

Borui Medicine




Borui Medicine


Copyright: Brilliant Biomedical (Suzhou) Co., Ltd. Website: CE Dongli · Suzhou Su ICP No. 18,000,014           

Copyright: Borui Biomedical (Suzhou) Co., Ltd. 

Powered by